Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2713 to 2762 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 1 (brefeldin a-inhibited gep 1) (p200 arf-gep1) (p200 arf guanine nucleotide exchange factor). [source:swissprot;acc:q9y6d6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.395\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00057\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to trna synthetase class ii. [source:refseq;acc:nm\_152268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.224\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00056\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
basic proline-rich peptide p-e (ib-9). [source:swissprot;acc:p02811]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.018\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.903\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00053\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
salivary proline-rich protein po (allele k) [contains: peptide p-d] (fragment). [source:swissprot;acc:p10162]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein, rp/eb family, member 2; t-cell activation protein, eb1 family; apc-binding protein eb1. [source:refseq;acc:nm\_014268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.634\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00052\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine-rich membrane protein ke4. [source:swissprot;acc:q92504]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.632\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein rp/eb family member 1 (apc-binding protein eb1). [source:swissprot;acc:q15691]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein rp/eb family member 3 (protein eb3). [source:swissprot;acc:q9upy8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
216.633\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional aminoacyl-trna synthetase [includes: glutamyl-trna synthetase (ec 6.1.1.17) (glutamate--trna ligase); prolyl-trna synthetase (ec 6.1.1.15) (proline--trna ligase)]. [source:swissprot;acc:p07814]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.116\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00043\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 2 protein (ws beta-transducin repeats protein) (ws-betatrp) (williams-beuren syndrome chromosome region 13 protein). [source:swissprot;acc:q9y4p3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.308\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.214\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b2. [source:swissprot;acc:q03252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.323\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.413\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00041\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-beta (hsp 84) (hsp 90). [source:swissprot;acc:p08238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.053\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.963\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
doublecortin (lissencephalin-x) (lis-x) (doublin). [source:swissprot;acc:o43602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.569\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00034\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.927\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00033\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 70 kda subunit (lupus ku autoantigen protein p70) (ku70) (70 kda subunit of ku antigen) (thyroid-lupus autoantigen) (tlaa) (ctc box binding factor 75 kda subunit) (ctcbf) (ctc75). [source:swissprot;acc:p12956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 80 kda subunit (lupus ku autoantigen protein p86) (ku86) (ku80) (86 kda subunit of ku antigen) (thyroid- lupus autoantigen) (tlaa) (ctc box binding factor 85 kda subunit) (ctcbf) (ctc85) (nuclear factor iv) (dna-repair protein xrcc5). [source:swissprot;acc:p13010]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-specific protease otubain 1. [source:refseq;acc:nm\_017670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
complement component 1, q subcomponent binding protein, mitochondrial precursor (glycoprotein gc1qbp) (gc1q-r protein) (hyaluronan-binding protein 1) (p32) (p33). [source:swissprot;acc:q07021]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.922\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.985\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0003\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sirtuin 1; sir2-like 1; sirtuin type 1; sir2alpha; sirtuin silent mating type information regulation 2 homolog 1 (s. cerevisiae). [source:refseq;acc:nm\_012238]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
general control of amino acid synthesis protein 5-like 2 (ec 2.3.1.-) (histone acetyltransferase gcn5) (hsgcn5). [source:swissprot;acc:q92830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.233\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.175\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00029\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p300/cbp-associated factor (ec 2.3.1.-) (p/caf) (histone acetylase pcaf). [source:swissprot;acc:q92831]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.229\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.172\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ischemia/reperfusion inducible protein. [source:refseq;acc:nm\_024640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.007\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00026\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-alpha (hsp 86). [source:swissprot;acc:p07900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.943\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00025\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor mafg (v-maf musculoaponeurotic fibrosarcoma oncogene homolog g) (hmaf). [source:swissprot;acc:o15525]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
198.278\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
198.321\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00022\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor maff (v-maf musculoaponeurotic fibrosarcoma oncogene homolog f) (u-maf). [source:swissprot;acc:q9ulx9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor mafk (erythroid transcription factor nf-e2 p18 subunit). [source:swissprot;acc:o60675]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell adhesion molecule with homology to l1cam precursor; neural cell adhesion molecule; cell adhesion molecule l1-like; l1 cell adhesion molecule 2. [source:refseq;acc:nm\_006614]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural cell adhesion molecule l1 precursor (n-cam l1) (cd171 antigen). [source:swissprot;acc:p32004]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 31 kda subunit (tafii-31) (tafii-32) (tafii32). [source:swissprot;acc:q16594]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor erythroid 2 related factor 1 (nf-e2 related factor 1) (nfe2-related factor 1) (nuclear factor, erythroid derived 2, like 1) (transcription factor 11) (transcription factor hbz17) (transcription factor lcr-f1) (locus control region-factor 1). [source:swissprot;acc:q14494]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor (erythroid-derived 2)-like 3; nf-e2-related factor 3. [source:refseq;acc:nm\_004289]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional adaptor 3-like isoform a. [source:refseq;acc:nm\_006354]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
201.476\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
201.514\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00019\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
frg1 protein (fshd region gene 1 protein). [source:swissprot;acc:q14331]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional adapter 2-like (ada2-like protein) (kl04p). [source:swissprot;acc:o75478]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bromodomain containing 7; bromodomain protein; bromodomain-containing 7. [source:refseq;acc:nm\_013263]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.477\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.00018\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small glutamine-rich tetratricopeptide repeat-containing protein (vpu-binding protein) (ubp). [source:swissprot;acc:o43765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
189.563\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00017\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte growth factor-regulated tyrosine kinase substrate; human growth factor-regulated tyrosine kinase substrate. [source:refseq;acc:nm\_004712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
190.522\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
190.496\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00014\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 7. [source:swissprot;acc:p83436]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 1 (ec 3.4.25.1) (proteasome component c2) (macropain subunit c2) (multicatalytic endopeptidase complex subunit c2) (proteasome nu chain) (30 kda prosomal protein) (pros-30). [source:swissprot;acc:p25786]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.338\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00012\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p53-related protein kinase (ec 2.7.1.-) (nori-2). [source:swissprot;acc:q96s44]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.716\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.859\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.846\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00006\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-formyltetrahydrofolate cyclo-ligase (ec 6.3.3.2) (5,10-methenyl- tetrahydrofolate synthetase) (methenyl-thf synthetase) (mthfs). [source:swissprot;acc:p49914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.638\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00002\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyhypusine synthase (ec 2.5.1.46) (dhs). [source:swissprot;acc:p49366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.403\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.401\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 1 (nap-1 related protein). [source:swissprot;acc:p55209]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 2 (brain-specific protein, x- linked). [source:swissprot;acc:q9ulw6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinoic acid receptor rxr-alpha. [source:swissprot;acc:p19793]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell acute lymphocytic leukemia-2 protein (tal-2 protein). [source:swissprot;acc:q16559]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
developmentally regulated gtp-binding protein 1 (drg 1). [source:swissprot;acc:q9y295]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/